![Katrine Bosley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Katrine Bosley
Direktor/Vorstandsmitglied bei
Biotechnology Innovation Organization
Profil
Katrine S.
Bosley is currently Director at Biotechnology Innovation Organization since 2015, Director at Massachusetts Eye & Ear Infirmary, Inc., and Venture Partner at Advent Venture Partners LLP since 2022.
Former positions include President & Chief Executive Officer at Avila Therapeutics, Inc. in 2009, President & Chief Executive Officer at Editas Medicine, Inc. in 2019, Chairman at Genocea Biosciences, Inc. from 2013 to 2018, Chairman at Arrakis Therapeutics, Inc. from 2019 to 2026, Director-Decision Support at Biogen, Inc., Independent Non-Executive Director at Lakefront Biotherapeutics from 2013 to 2022, Director at CoCo Therapeutics Ltd., Director at Scholar Rock, Inc., Principal at Alkermes, Inc., Vice President-Strategic Operations at Adnexus from 2004 to 2008, and President-Celgene Avilomics Research at Celgene LLC in 2012.
Education includes an undergraduate degree from Cornell University conferred in 1990.
Aktive Positionen von Katrine Bosley
| Unternehmen | Position | Beginn |
|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Direktor/Vorstandsmitglied | 01.06.2015 |
Massachusetts Eye & Ear Infirmary, Inc.
 Massachusetts Eye & Ear Infirmary, Inc. Medical/Nursing ServicesHealth Services Provides vision and hearing treatments | Direktor/Vorstandsmitglied | - |
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners invests in middle market companies located in the United Kingdom, Europe and the United States. The firm focuses on life sciences such as new drug discovery across all modalities, med tech, enabling technologies and vaccines. It participates in seed and early stage capital requirements. | Private Equity Investor | 01.05.2022 |
Ehemalige bekannte Positionen von Katrine Bosley
| Unternehmen | Position | Ende |
|---|---|---|
Arrakis Therapeutics, Inc.
 Arrakis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops RNA-targeted small molecules on neurologic diseases, cancer and rare genetic diseases | Vorsitzender | 29.06.2026 |
| LAKEFRONT BIOTHERAPEUTICS NV | Direktor/Vorstandsmitglied | 26.04.2022 |
| EDITAS MEDICINE, INC. | Vorstandsvorsitzender | 01.03.2019 |
Celgene LLC | Corporate Officer/Principal | 01.05.2012 |
Avila Therapeutics, Inc.
 Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops covalent drugs | Vorstandsvorsitzender | 01.03.2012 |
Ausbildung von Katrine Bosley
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
91
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners invests in middle market companies located in the United Kingdom, Europe and the United States. The firm focuses on life sciences such as new drug discovery across all modalities, med tech, enabling technologies and vaccines. It participates in seed and early stage capital requirements. | Finance |
Galapagos NV
 Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Develops medicines which includes protein antagonists | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Eye & Ear Infirmary, Inc.
Massachusetts Eye & Ear Infirmary, Inc. Medical/Nursing ServicesHealth Services Provides vision and hearing treatments | Health Services |
Avila Therapeutics, Inc.
Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops covalent drugs | Health Technology |
CoCo Therapeutics Ltd.
 CoCo Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops novel treatment for Alzheimer's disease | Health Technology |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Celgene LLC | |
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Arrakis Therapeutics, Inc.
Arrakis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops RNA-targeted small molecules on neurologic diseases, cancer and rare genetic diseases | Health Technology |
Wählen Sie MarketScreener 
